title: Remission of adult acute lymphocytic leukaemia with alemtuzumab.
authors.forename: J P
authors.initials: JP
authors.lastname: Laporte
authors.forename: F
authors.initials: F
authors.lastname: Isnard
authors.forename: L
authors.initials: L
authors.lastname: Garderet
authors.forename: L
authors.initials: L
authors.lastname: Fouillard
authors.forename: N-C
authors.initials: NC
authors.lastname: Gorin
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000473:pathology; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab